home / stock / artl / artl news


ARTL News and Press, Artelo Biosciences Inc. From 01/11/22

Stock Information

Company Name: Artelo Biosciences Inc.
Stock Symbol: ARTL
Market: OTC
Website: artelobio.com

Menu

ARTL ARTL Quote ARTL Short ARTL News ARTL Articles ARTL Message Board
Get ARTL Alerts

News, Short Squeeze, Breakout and More Instantly...

ARTL - Artelo Anticipates Accelerated Clinical Development for ART27.13 Following Its Classification Change in the United Kingdom

SOLANA BEACH, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) announced that the United Kingdom’s Home Office has classified the Company’s lead clinical cannabinoid, ART27.13 , as “non-controlled” and, therefore, is no lo...

ARTL - Artelo Biosciences Leadership to Participate on Endocannabinoid Panel at the H.C. Wainwright BioConnect 2022 Virtual Conference

SOLANA BEACH, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL) , a clinical stage pharmaceutical company developing therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, today announced that it will be pa...

ARTL - Artelo Biosciences EPS beats by $0.03

Artelo Biosciences (NASDAQ:ARTL): FY GAAP EPS of -$0.40 beats by $0.03. Press Release As of August 31, 2021, the Company had approximately $10.07M in cash and marketable securities, compared to $2.14M as of August 31, 2020. For further details see: Artelo Biosciences EPS beats by $0.03 ...

ARTL - Artelo Biosciences Reports Fiscal 2021 Year-End Financial Results and Provides Business Update

SOLANA BEACH, Calif., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) , a clinical stage pharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the endocannabinoid system, today reported financial and operating ...

ARTL - Q4 Investor Summit Small Cap & Micro Cap Conference To Offer Opportunity to Meet with C-level Management of 90+ Companies

Small and Micro-cap investors are invited to attend the Q4 Investor Summit being held on November 16-17, 2021. The event is organized by the Investor Summit Group, recognised as a highly reputed brand for hosting North America’s largest independent investor conferences. Over 90 pre...

ARTL - Artelo Biosciences to Present at the Q4 Investor Summit on November 17th

Solana Beach, California--(Newsfile Corp. - November 11, 2021) - Artelo Biosciences, Inc. (NASDAQ: ARTL) , a clinical stage pharmaceutical company developing therapeutics that modulate endogenous signaling pathways, including the endocannabinoid system, today announced that management wil...

ARTL - Best Penny Stocks to Watch in Mid-November 2021

Are These Penny Stocks Worth Watching This Week? With another week of trading penny stocks and blue chips almost here, there are hundreds of options to choose from. But as traders, it’s our job to find the best penny stocks to buy for both the greatest chance of profitability...

ARTL - Are These Trending Penny Stocks Worth Buying at Current Levels?

3 Trending Penny Stocks That Could Be Worth Watching Right Now Using the latest trends to find penny stocks is one of the best ways to stay ahead in the market. And while finding trending penny stocks alone is not enough to make money with small caps, using current industry news and...

ARTL - BGVF, VYNT and SNMP among pre market gainers

Evaxion Biotech (NASDAQ:EVAX) +219%. TDH Holdings (NASDAQ:PETZ) +66%. NeoPhotonics NPTN +35% on Q3 earnings. QuinStreet QNST +26% on Q1 earnings. Artelo Biosciences (NASDAQ:ARTL) +22%. Concert Pharmaceuticals CNCE +25% signs agreement to raise $65M financing Cros...

ARTL - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We’re getting right into the thick of it today with a look at the biggest pre-market stock movers for Tuesday. Source: f11photo/Shutterstock.com We’ve got earnings reports, analys...

Previous 10 Next 10